Wilton S - Search Results

1

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.

Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy. Dominici M, et al. Among authors: wilton s. Cytotherapy. 2015 Dec;17(12):1663-6. doi: 10.1016/j.jcyt.2015.10.007. Cytotherapy. 2015. PMID: 26589750 No abstract available.

2

Gene therapy: therapeutic applications and relevance to pathology.

Both G, Alexander I, Fletcher S, Nicolson TJ, Rasko JE, Wilton SD, Symonds G. Both G, et al. Among authors: wilton sd. Pathology. 2011 Oct;43(6):642-56. doi: 10.1097/PAT.0b013e32834b1dad. Pathology. 2011. PMID: 21897331 Review.

3

Part 2: Making the "unproven" "proven".

Weiss DJ, Rasko JE, Cuende N, Ruiz MA, Ho HN, Nordon R, Wilton S, Dominici M, Srivastava A. Weiss DJ, et al. Among authors: wilton s. Cytotherapy. 2016 Jan;18(1):120-3. doi: 10.1016/j.jcyt.2015.11.005. Cytotherapy. 2016. PMID: 26719203 Free article. No abstract available.

4

Induced dystrophin exon skipping in human muscle explants.

McClorey G, Fall AM, Moulton HM, Iversen PL, Rasko JE, Ryan M, Fletcher S, Wilton SD. McClorey G, et al. Among authors: wilton sd. Neuromuscul Disord. 2006 Oct;16(9-10):583-90. doi: 10.1016/j.nmd.2006.05.017. Epub 2006 Aug 21. Neuromuscul Disord. 2006. PMID: 16919955

5

Snapback SSCP analysis: engineered conformation changes for the rapid typing of known mutations.

Wilton SD, Honeyman K, Fletcher S, Laing NG. Wilton SD, et al. Hum Mutat. 1998;11(3):252-8. doi: 10.1002/(SICI)1098-1004(1998)11:3<252::AID-HUMU11>3.0.CO;2-Y. Hum Mutat. 1998. PMID: 9521428

6

Gene therapy and molecular approaches to the treatment of hereditary muscular disorders.

Fletcher S, Wilton SD, Howell JM. Fletcher S, et al. Among authors: wilton sd. Curr Opin Neurol. 2000 Oct;13(5):553-60. doi: 10.1097/00019052-200010000-00008. Curr Opin Neurol. 2000. PMID: 11073362 Review.

7

Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy.

Fletcher S, Ly T, Duff RM, McC Howell J, Wilton SD. Fletcher S, et al. Among authors: wilton sd. Neuromuscul Disord. 2001 Apr;11(3):239-43. doi: 10.1016/s0960-8966(00)00187-5. Neuromuscul Disord. 2001. PMID: 11297938

8

Evaluation of a short interspersed nucleotide element in the 3' untranslated region of the defective dystrophin gene of dogs with muscular dystrophy.

Fletcher S, Carville KS, Howell JM, Mann CJ, Wilton SD. Fletcher S, et al. Among authors: wilton sd. Am J Vet Res. 2001 Dec;62(12):1964-8. doi: 10.2460/ajvr.2001.62.1964. Am J Vet Res. 2001. PMID: 11763189 Free article.

9

Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy.

Mann CJ, Honeyman K, McClorey G, Fletcher S, Wilton SD. Mann CJ, et al. Among authors: wilton sd. J Gene Med. 2002 Nov-Dec;4(6):644-54. doi: 10.1002/jgm.295. J Gene Med. 2002. PMID: 12439856

10

Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.

Errington SJ, Mann CJ, Fletcher S, Wilton SD. Errington SJ, et al. Among authors: wilton sd. J Gene Med. 2003 Jun;5(6):518-27. doi: 10.1002/jgm.361. J Gene Med. 2003. PMID: 12797117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters